Clinical Trials Browser

Lymphoma, Non-Hodgkin × Interleukin-18 × Clear all

NCT01768338 2023-02-10

Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma

Phase 1 Completed

Lymphoma, Non-Hodgkin

NCT00500058 2017-07-26

A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18

Phase 1 Completed

Lymphoma, Non-Hodgkin, Neoplasms